Literature DB >> 2484513

Selenium in total parenteral nutrition.

H B von Stockhausen1.   

Abstract

In clinical practice, selenium deficiency may arise under conditions of chronic malnutrition and especially after long-term total parenteral nutrition (TPN). In infants receiving long-term TPN, we observed plasma selenium levels as low as those previously reported in Chinese children with Keshan disease. Low plasma selenium levels were also usually associated with very low activities of glutathione peroxidase. Although clinical symptoms of selenium deficiency did not occur in our patients, several cases have been described in the literature, indicating the need for supplementation in TPN. In order to derive at the appropriate dosage, it is proposed to correlate it with the total protein supply. According to our present knowledge, .5-1.0 micrograms selenium/g of protein appears to be adequate to keep patients in Se balance. For Se repletion of body stores, this dosage has been increased up to 3 micrograms of Se/g of protein. Advantages and disadvantages of selenite and of selenomethionine as possible supplemental forms of Se for TPN solutions are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2484513     DOI: 10.1007/bf02990133

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  15 in total

1.  Selenium deficiency in total parenteral nutrition.

Authors:  A M van Rij; C D Thomson; J M McKenzie; M F Robinson
Journal:  Am J Clin Nutr       Date:  1979-10       Impact factor: 7.045

2.  The selenium state of healthy children. I. Serum selenium concentration at different ages; activity of glutathione peroxidase of erythrocytes at different ages; selenium content of food of infants.

Authors:  I Lombeck; K Kasperek; H D Harbisch; L E Feinendegen; H J Bremer
Journal:  Eur J Pediatr       Date:  1977-04-26       Impact factor: 3.183

3.  Selenium supplementation during parenteral and enteral nutrition, short- and long-term effects of two derivatives.

Authors:  J Nève; F Vertongen; N Thonnart; Y A Carpentier; Y Grégoire; L Molle
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1986

4.  Distribution of superoxide dismutase and glutathione peroxidase in the carp: erythrocyte manganese SOD.

Authors:  F Mazeaud; J Maral; A M Michelson
Journal:  Biochem Biophys Res Commun       Date:  1979-02-28       Impact factor: 3.575

5.  An occidental case of cardiomyopathy and selenium deficiency.

Authors:  R A Johnson; S S Baker; J T Fallon; E P Maynard; J N Ruskin; Z Wen; K Ge; H J Cohen
Journal:  N Engl J Med       Date:  1981-05-14       Impact factor: 91.245

6.  Enhanced lung toxicity of paraquat in selenium-deficient rats.

Authors:  S T Omaye; K A Reddy; C E Cross
Journal:  Toxicol Appl Pharmacol       Date:  1978-02       Impact factor: 4.219

7.  Selenium: biochemical role as a component of glutathione peroxidase.

Authors:  J T Rotruck; A L Pope; H E Ganther; A B Swanson; D G Hafeman; W G Hoekstra
Journal:  Science       Date:  1973-02-09       Impact factor: 47.728

8.  Selenium in premature infants.

Authors:  S Amin; S Y Chen; P J Collipp; M Castro-Magana; V T Maddaiah; S W Klein
Journal:  Nutr Metab       Date:  1980       Impact factor: 4.169

9.  Vitamin E and selenium status of patients receiving short-term total parenteral nutrition.

Authors:  C D McGee; M J Ostro; R Kurian; K N Jeejeebhoy
Journal:  Am J Clin Nutr       Date:  1985-09       Impact factor: 7.045

Review 10.  Selenium deficiency.

Authors:  J Nève; F Vertongen; L Molle
Journal:  Clin Endocrinol Metab       Date:  1985-08
View more
  3 in total

Review 1.  Selenium metabolism and bioavailability.

Authors:  L A Daniels
Journal:  Biol Trace Elem Res       Date:  1996-09       Impact factor: 3.738

Review 2.  Zinc, copper and selenium in reproduction.

Authors:  R S Bedwal; A Bahuguna
Journal:  Experientia       Date:  1994-07-15

3.  Selenium, copper, zinc and hypertension: an analysis of the National Health and Nutrition Examination Survey (2011-2016).

Authors:  Mrigendra M Bastola; Craig Locatis; Richard Maisiak; Paul Fontelo
Journal:  BMC Cardiovasc Disord       Date:  2020-01-31       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.